Regulation of crystal induced inflammation: current understandings and clinical implications

References

• Oliviero F, Bindoli S, Scanu A, et al. Autoinflammatory mechanisms in crystal-induced arthritis. Front Med (Lausanne). 2020;7:166.
   PubMed Web of Science ®Google Scholar
• Niyonzima N, Bakke SS, Gregersen I, et al. Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis. EBioMedicine. 2020;60:102985.
   PubMed Web of Science ®Google Scholar
• Mulay SR, Kulkarni OP, Rupanagudi KV, et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion. J Clin Invest. 2013;123(1):236–246.
   PubMed Web of Science ®Google Scholar
• Hoy RF, Chambers DC. Silica-related diseases in the modern world. Allergy. 2020;75(11):2805–2817.
   PubMed Web of Science ®Google Scholar
• Mulay SR, Anders HJ. Crystallopathies. N Engl J Med. 2016;374(25):2465–2476.
   PubMed Web of Science ®Google Scholar
• Poloni LN, Ward MD. The materials science of pathological crystals. Chem Mater. 2014;26(1):477–495.
   Web of Science ®Google Scholar
• Tabas I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J Clin Investig. 2002;110(7):905–991.
   PubMed Web of Science ®Google Scholar
• Sedaghat A, Grundy SM. Cholesterol crystals and the formation of cholesterol gallstones. N Engl J Med. 1980;302(23):1274–1277.
   PubMed Web of Science ®Google Scholar
• Duewell P, Kono H, Rayner KJ, et al., NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464(7293):1357–1361.
   PubMed Web of Science ®Google Scholar
• Lee S, Matsuzaki H, Kumagai-Takei N, et al. Silica exposure and altered regulation of autoimmunity. Environ Health Prev Med. 2014;19(5):322–329].
   Web of Science ®Google Scholar
• Sheng X. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation. J Am Soc Nephrol. 2005;16(7):1904–1908.
   PubMedGoogle Scholar
• Abhishek A, Doherty M. Update on calcium pyrophosphate deposition. Clin Exp Rheumatol. 2016;34(4 Suppl 98):32–38.
   PubMed Web of Science ®Google Scholar
• McCarthy GM, Dunne A. Calcium crystal deposition diseases - beyond gout. Nat Rev Rheumatol. 2018;14(10):592–602.
   PubMed Web of Science ®Google Scholar
• Scanu A, Oliviero F, Luisetto R, et al. Effect of pathogenic crystals on the production of pro- and anti-inflammatory cytokines by different leukocyte populations. Immunobiology. 2021;226(1):152042.
   PubMed Web of Science ®Google Scholar
• Baggio C, Sfriso P, Cignarella A, et al. Phagocytosis and inflammation in crystal-induced arthritis: a synovial fluid and in vitro study. Clin Exp Rheumatol. 2020;39(3):494–500. Jul 21 (Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Ea HK, Chobaz V, Nguyen C, et al. Pathogenic Role of Basic Calcium Phosphate Crystals in Destructive Arthropathies. Plos One. 2013;8(2):e57352.
   PubMed Web of Science ®Google Scholar
• Punzi L, Scanu A, Spinella P, et al. One year in review 2018: gout. Clin Exp Rheumatol. 2019;37(1):1–11.
   PubMed Web of Science ®Google Scholar
• Pascual E, Addadi L, Andrés M, et al. Mechanisms of crystal formation in gout-a structural approach. Nat Rev Rheumatol. 2015;11(12):725–730.
   PubMed Web of Science ®Google Scholar
• Martinon F, Pétrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237–241.
   PubMed Web of Science ®Google Scholar
• Li Y, Cao X, Liu Y, et al. Neutrophil Extracellular Traps Formation and Aggregation Orchestrate Induction and Resolution of Sterile Crystal-Mediated Inflammation. Front Immunol. 2018;9:1559.
   PubMed Web of Science ®Google Scholar
• Mulay SR, Desai J, Kumar SV, et al. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat Commun. 2016;7(1):10274.
   PubMedGoogle Scholar
• Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243(1):206–214.
   PubMed Web of Science ®Google Scholar
• Gordon S. Phagocytosis: an Immunobiologic Process. Immunity. 2016;44(3):463–475.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Lioté F. Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Joint Bone Spine. 2005;72(4):295–302.
   PubMed Web of Science ®Google Scholar
• Neumann K, Castiñeiras-Vilariño M, Höckendorf U, et al. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death. Immunity. 2014;40(3):389–399.
   PubMed Web of Science ®Google Scholar
• Terkeltaub R, Zachariae C, Santoro D, et al. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum. 1991;34(7):894–903.
   PubMed Web of Science ®Google Scholar
• Alberts A, Klingberg A, Hoffmeister L, et al. Binding of Macrophage Receptor MARCO, LDL, and LDLR to Disease-Associated Crystalline Structures. Front Immunol. 2020;11:596103.
   PubMed Web of Science ®Google Scholar
• Alberts A, Klingberg A, Wessig AK, et al. C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1. Sci Rep. 2020 Apr 14;10(1):6391. https://doi.org/10.1038/s41598-020-63318-8.
   PubMed Web of Science ®Google Scholar
• Russell IJ, Mansen C, Kolb LM, et al. Activation of the fifth component of human complement (C5) induced by monosodium urate crystals: C5 convertase assembly on the crystal surface. Clin Immunol Immunopathol. 1982;24(2):239–250.
   PubMedGoogle Scholar
• Ng G, Sharma K, Ward SM, et al., Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity. 2008;29(5):807–818.
   PubMed Web of Science ®Google Scholar
• Nguyen C, Lieberherr M, Bordat C, et al. Intracellular calcium oscillations in articular chondrocytes induced by basic calcium phosphate crystals lead to cartilage degradation. Osteoarthritis Cartilage. 2012;20(11):1399–1408.
   PubMed Web of Science ®Google Scholar
• Pieterse E, Jeremic I, Czegley C, et al. Blood-borne phagocytes internalize urate microaggregates and prevent intravascular NETosis by urate crystals. Sci Rep. 2016;6(1):38229.
   PubMedGoogle Scholar
• Gong T, Yang Y, Jin T, et al. Orchestration of NLRP3 Inflammasome Activation by Ion Fluxes. Trends Immunol. 2018;39(5):393–406.
   PubMed Web of Science ®Google Scholar
• Mu L, Tu Z, Miao L, et al. A phosphatidylinositol 4,5-bisphosphate redistribution-based sensing mechanism initiates a phagocytosis programing. Nat Commun. 2018 Oct 15;9(1):4259.
   PubMedGoogle Scholar
• Onai N, Ogasawara C. Calcium Pyrophosphate Dihydrate Crystals Increase the Granulocyte/Monocyte Progenitor (GMP) and Enhance Granulocyte and Monocyte Differentiation In Vivo. Int J Mol Sci. 2020;22(1):262.
   Web of Science ®Google Scholar
• Guma M, Ronacher L, Liu-Bryan R, et al. 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum. 2009;60(12):3642–3650.
   PubMedGoogle Scholar
• Tatsiy O, Mayer TZ, de Carvalho Oliveira V, et al. Cytokine Production and NET Formation by Monosodium Urate-Activated Human Neutrophils Involves Early and Late Events, and Requires Upstream TAK1 and Syk. Front Immunol. 2020 Jan 15;10:2996.
   PubMed Web of Science ®Google Scholar
• Singh AK, Haque M, O’Sullivan K, et al. Suppression of monosodium urate crystal-induced inflammation by inhibiting TGF-β-activated kinase 1-dependent signaling: role of the ubiquitin proteasome system. Cell Mol Immunol. 2021 Jan;18(1):162–170.
   PubMed Web of Science ®Google Scholar
• Galozzi P, Bindoli S, Doria A, et al. The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities. Autoimmun Rev. 2021;20(4):102785.
   PubMed Web of Science ®Google Scholar
• Okada M, Matsuzawa A, Yoshimura A, et al. The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation. J Biol Chem. 2014;289(47):32926–32936.
   PubMed Web of Science ®Google Scholar
• Campden RI, Zhang Y. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation. Arch Biochem Biophys. 2019;670:32–42.
   PubMed Web of Science ®Google Scholar
• Huang Q, Gao W, Mu H, et al. HSP60 Regulates Monosodium Urate Crystal-Induced Inflammation by Activating the TLR4-NF-κB-MyD88 Signaling Pathway and Disrupting Mitochondrial Function. Oxid Med Cell Longev. 2020;2020:8706898.
   PubMed Web of Science ®Google Scholar
• Schorn C, Frey B, Lauber K, et al. Sodium overload and water influx activate the NALP3 inflammasome. J Biol Chem. 2011;286(1):35–41.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Matsumoto H, Roh M, et al. Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci U S A. 2012;109(36):14598–14603.
   PubMed Web of Science ®Google Scholar
• Malik A, Kanneganti TD. Inflammasome activation and assembly at a glance. J Cell Sci. 2017;130(23):3955–3963.
   PubMed Web of Science ®Google Scholar
• Holzinger D, Nippe N, Vogl T, et al. Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout. Arthritis Rheumatol. 2014;66(5):1327–1339.
   PubMed Web of Science ®Google Scholar
• Crișan TO, Cleophas MC, Oosting M, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis. 2016;75(4):755–762.
   PubMed Web of Science ®Google Scholar
• An LL, Mehta P, Xu L, et al., Complement C5a potentiates uric acid crystal-induced IL-1β production. Eur J Immunol. 2014;44(12):3669–3679.
   PubMed Web of Science ®Google Scholar
• Shaw OM, Steiger S, Liu X, et al. Brief report: granulocyte-macrophage colony-stimulating factor drives monosodium urate monohydrate crystal-induced inflammatory macrophage differentiation and NLRP3 inflammasome up-regulation in an in vivo mouse model. Arthritis Rheumatol. 2014;66(9):2423–2428.
   PubMed Web of Science ®Google Scholar
• Scanu A, Oliviero F, Gruaz L, et al. Synovial fluid proteins are required for the induction of interleukin-1β production by monosodium urate crystals. Scand J Rheumatol. 2016;45(5):384–393.
   PubMed Web of Science ®Google Scholar
• Joosten LA, Netea MG, Mylona E, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010;62(11):3237–3248.
   PubMedGoogle Scholar
• Vieira AT, Macia L, Galvão I, et al. A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout. Arthritis Rheumatol. 2015;67(6):1646–1656.
   PubMed Web of Science ®Google Scholar
• Hari A, Zhang Y, Tu Z, et al., Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci Rep. 2014;4(1):7281.
   PubMedGoogle Scholar
• Mariotte A, De Cauwer A, Po C, et al. A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients. Theranostics. 2020;10(5):2158–2171.
   PubMed Web of Science ®Google Scholar
• Joosten LA, Netea MG, Fantuzzi G, et al. Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 2009;60(12):3651–3662.
   PubMed Web of Science ®Google Scholar
• Desai J, Kumar SV, Mulay SR, et al. PMA and crystal-induced neutrophil extracellular trap formation involves RIPK1-RIPK3-MLKL signaling. Eur J Immunol. 2016;46(1):223–229.
   PubMed Web of Science ®Google Scholar
• Linkermann A, Stockwell BR, Krautwald S, et al. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat Rev Immunol. 2014;14(11):759–767.
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Stowe IB, Lee BL, et al. Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature. 2015;526(7575):666–671.
   PubMed Web of Science ®Google Scholar
• Li H, Jiang W, Ye S, et al., P2Y14 receptor has a critical role in acute gouty arthritis by regulating pyroptosis of macrophages. Cell Death Dis. 2020;11(5):394.
   PubMed Web of Science ®Google Scholar
• Oliviero F, Scanu A. How Factors Involved in the Resolution of Crystal-Induced Inflammation Target IL-1β. Front Pharmacol. 2017;8:164.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Akahoshi T, Kawai S, et al. Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches. Arthritis Rheum. 2002;46(9):2504–2513.
   PubMedGoogle Scholar
• Landis RC, Yagnik DR, Florey O, et al., Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum. 2002;46(11):3026–3033. https://doi.org/10.1002/art.10614.
   PubMedGoogle Scholar
• Galozzi P, Maschio L, Carraro S, et al. M2 macrophages as resolvers of crystal-induced inflammation Rheumatology (Oxford) 2021;60(5):2480-2483. .
   Google Scholar
• Liu L, Zhu X, Zhao T, et al. Sirt1 ameliorates monosodium urate crystal-induced inflammation by altering macrophage polarization via the PI3K/Akt/STAT6 pathway. Rheumatology (Oxford). 2019;58(9):1674–1683.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zou Y, Zheng J, et al. lncRNA‑MM2P downregulates the production of pro‑inflammatory cytokines in acute gouty arthritis. Mol Med Rep. 2020;22(3):2227–2234.
   PubMed Web of Science ®Google Scholar
• Li K, Neumann K, Duhan V, et al. The uric acid crystal receptor Clec12A potentiates type I interferon responses. Proc Natl Acad Sci U S A. 2019;116(37):18544–18549.
   PubMed Web of Science ®Google Scholar
• Akahoshi T, Namai R, Murakami Y, et al. Rapid induction of peroxisome proliferator-activated receptor gamma expression in human monocytes by monosodium urate monohydrate crystals. Arthritis Rheum. 2003;48(1):231–239.
   PubMedGoogle Scholar
• Getting SJ, Lam CW, Chen AS, et al. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 2006;20(13):2234–2241.
   PubMed Web of Science ®Google Scholar
• Duan L, Luo J, Fu Q, et al. Decreased Expression of CD14 in MSU-Mediated Inflammation May Be Associated with Spontaneous Remission of Acute Gout. J Immunol Res. 2019 Jun 13;2019:7143241.
   PubMed Web of Science ®Google Scholar
• Van Avondt K, van der Linden M, Naccache PH, et al. Signal Inhibitory Receptor on Leukocytes-1 Limits the Formation of Neutrophil Extracellular Traps, but Preserves Intracellular Bacterial Killing. J Immunol. 2016;196(9):3686–3694.
   PubMed Web of Science ®Google Scholar
• Pang L, Hayes CP, Buac K, et al. Pseudogout-associated inflammatory calcium pyrophosphate dihydrate microcrystals induce formation of neutrophil extracellular traps. J Immunol. 2013;190(12):6488–6500.
   PubMed Web of Science ®Google Scholar
• Schauer C, Janko C, Munoz LE, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511–517.
   PubMed Web of Science ®Google Scholar
• Jeong JH, Choi SJ, Ahn SM, et al. Neutrophil extracellular trap clearance by synovial macrophages in gout. Arthritis Res Ther. 2021;23(1):88.
   PubMed Web of Science ®Google Scholar
• Scanu A, Luisetto R, Oliviero F, et al. High-density lipoproteins inhibit urate crystal-induced inflammation in mice. Ann Rheum Dis. 2015 Mar;74(3):587–594.
   PubMed Web of Science ®Google Scholar
• Renaudin F, Sarda S, Campillo-Gimenez L, et al. Adsorption of Proteins on m-CPPD and Urate Crystals Inhibits Crystal-induced Cell Responses: study on Albumin-crystal Interaction. J Funct Biomater. 2019;10(2):18.
   Web of Science ®Google Scholar
• Joosten LA, Crişan TO, Azam T, et al. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra. Ann Rheum Dis. 2016;75(6):1219–1227.
   PubMed Web of Science ®Google Scholar
• Zhou W, Wang Y, Wu R, et al. MicroRNA-488 and −920 regulate the production of proinflammatory cytokines in acute gouty arthritis. Arthritis Res Ther. 2017;19(1):203.
   PubMedGoogle Scholar
• Ma T, Liu X, Cen Z, et al. MicroRNA-302b negatively regulates IL-1β production in response to MSU crystals by targeting IRAK4 and EphA2. Arthritis Res Ther. 2018;20(1):34.
   PubMedGoogle Scholar
• Yagnik D. Macrophage derived platelet activating factor implicated in the resolution phase of gouty inflammation. Int J Inflam. 2014;2014:526496.
   PubMedGoogle Scholar
• Youm YH, Nguyen KY, Grant RW, et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263–269.
   PubMed Web of Science ®Google Scholar
• Cumpelik A, Ankli B, Zecher D, et al. Neutrophil microvesicles resolve gout by inhibiting C5a-mediated priming of the inflammasome. Ann Rheum Dis. 2016;75(6):1236–1245.
   PubMed Web of Science ®Google Scholar
• Chhana A, Dalbeth N. The gouty tophus: a review. Curr Rheumatol Rep. 2015;17:19.
   PubMed Web of Science ®Google Scholar
• Joosten LA, Abdollahi-Roodsaz S, Dinarello CA, et al. Toll-like receptors and chronic inflammation in rheumatic diseases: new developments. Nat Rev Rheumatol. 2016;12(6):344–357.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Pritzker K, Firestein GS, et al. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol. 2005;174(8):5016–5023.
   PubMed Web of Science ®Google Scholar
• Yagnik DR, Evans BJ, Florey O, et al. Macrophage release of transforming growth factor beta1 during resolution of monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2004;50(7):2273–2280.
   PubMedGoogle Scholar
• Schlesinger N, Thiele RG. The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis. 2010;69(11):1907–1912.
   PubMed Web of Science ®Google Scholar
• Kaneko K, Iwamoto H, Yasuda M, et al. Proteomic analysis to examine the role of matrix proteins in a gouty tophus from a patient with recurrent gout. Nucleosides Nucleotides Nucleic Acids. 2014;33(4–6):199–207.
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez E, Gamberucci A, Lucherini OM, et al. Neutrophil extracellular traps release in gout and pseudogout depends on the number of crystals regardless of leukocyte count. Rheumatology (Oxford). 2021; keab087. https://doi.org/10.1093/rheumatology/keab087.
   Google Scholar
• Chen CJ, Shi Y, Hearn A, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest. 2006;116(8):2262–2271.
   PubMed Web of Science ®Google Scholar
• Ligthart S, Vaez A, Võsa U, et al. Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. Am J Hum Genet. 2018;103(5):691–706.
   PubMed Web of Science ®Google Scholar
• Merriman TR. An update on the genetic architecture of hyperuricemia and gout. Arthritis Res Ther. 2015;17(1):98.
   PubMedGoogle Scholar
• Chang SJ, Tsai PC, Chen CJ, et al. The polymorphism −863C/A in tumour necrosis factor-alpha gene contributes an independent association to gout. Rheumatology (Oxford). 2007;46(11):1662–1666.
   PubMed Web of Science ®Google Scholar
• Rasheed H, McKinney C, Stamp LK, et al. The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. PLoS One. 2016;11(1):e0147939.
   PubMed Web of Science ®Google Scholar
• Chen Y, Ren X, Li C, et al. CARD8 rs2043211 polymorphism is associated with gout in a Chinese male population. Cell Physiol Biochem. 2015;35(4):1394–1400.
   PubMedGoogle Scholar
• McKinney C, Stamp LK, Dalbeth N, et al. Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. Arthritis Res Ther. 2015;17(1):288.
   PubMedGoogle Scholar
• Chang WC, Jan WYJ, Chung WH, et al. Genetic variants of PPAR-gamma coactivator 1B augment NLRP3-mediated inflammation in gouty arthritis. Rheumatology (Oxford). 2017;56(3):457–466.
   PubMed Web of Science ®Google Scholar
• Deng J, Lin W, Chen Y, et al. rs3806268 of NLRP3 gene polymorphism is associated with the development of primary gout. Int J Clin Exp Pathol. 2015;8(10):13747–13752.
   PubMed Web of Science ®Google Scholar
• Delgado-Lista J, Garcia-Rios A, Perez-Martinez P, et al. Interleukin 1B variant-1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism. J Clin Endocrinol Metab. 2011;96(5):E816–E820.
   PubMed Web of Science ®Google Scholar
• Cleophas MCP, Crişan TO, Klück V, et al. Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression. Arthritis Res Ther. 2019;21(1):50.
   PubMedGoogle Scholar
• Wang X, Chi J, Dong B, et al. MiR-223-3p and miR-22-3p inhibit monosodium urate-induced gouty inflammation by targeting NLRP3. Int J Rheum Dis. 2021;24(4):599–607.
   PubMed Web of Science ®Google Scholar
• Hu J, Wu H, Wang D, et al. LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis. Biochimie. 2019;157:102–110.
   PubMed Web of Science ®Google Scholar
• Xu YT, Leng YR, Liu MM, et al. MicroRNA and long noncoding RNA involvement in gout and prospects for treatment. Int Immunopharmacol. 2020;87:106842.
   PubMed Web of Science ®Google Scholar
• Di Giovine FS, Malawista SE, Nuki G, et al. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol. 1987;138(10):3213–3218.
   PubMed Web of Science ®Google Scholar
• Oliviero F, Zamudio-Cuevas Y, Belluzzi E, et al. Polydatin and Resveratrol Inhibit the Inflammatory Process Induced by Urate and Pyrophosphate Crystals in THP-1 Cells. Foods. 2019;8(11):560.
   Web of Science ®Google Scholar
• Pazár B, Ea HK, Narayan S, et al. Basic calcium phosphate crystals induce monocyte/macrophage IL-1β secretion through the NLRP3 inflammasome in vitro. J Immunol. 2011;186(4):2495–2502. https://doi.org/10.4049/jimmunol.1001284.
   PubMed Web of Science ®Google Scholar
• Bousoik E, Qadri M, Elsaid KA. CD44 Receptor Mediates Urate Crystal Phagocytosis by Macrophages and Regulates Inflammation in A Murine Peritoneal Model of Acute Gout. Sci Rep. 2020;10(1):5748.
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Mouktaroudi M, Bodar E, et al. Crystals of monosodium urate monohydrate enhance lipopolysaccharide-induced release of interleukin 1 beta by mononuclear cells through a caspase 1-mediated process. Ann Rheum Dis. 2009;68(2):273–278.
   PubMed Web of Science ®Google Scholar
• Luz HL, Reichel M, Unwin RJ, et al. P2X7 Receptor Stimulation Is Not Required for Oxalate Crystal-Induced Kidney Injury. Sci Rep. 2019 Dec 27;9(1):20086.
   PubMedGoogle Scholar
• Mylona EE, Mouktaroudi M, Crisan TO, et al. Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals. Arthritis Res Ther. 2012 Jul 4;14(4):R158.
   PubMed Web of Science ®Google Scholar
• Braga TT, Forni MF, Correa-Costa M, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7(1):39884.
   PubMedGoogle Scholar
• Ma Q, Honarpisheh M, Li C, et al. Soluble Uric Acid Is an Intrinsic Negative Regulator of Monocyte Activation in Monosodium Urate Crystal-Induced Tissue Inflammation. J Immunol. 2020;205(3):789–800.
   PubMed Web of Science ®Google Scholar
• Davidsson L, Dahlstrand Rudin A, Sanchez Klose FP, et al. In Vivo Transmigrated Human Neutrophils Are Highly Primed for Intracellular Radical Production Induced by Monosodium Urate Crystals. Int J Mol Sci. 2020;21(11):3750.
   Web of Science ®Google Scholar
• Scanu A, Oliviero F, Gruaz L, et al. High-density lipoproteins downregulate CCL2 production in human fibroblast-like synoviocytes stimulated by urate crystals. Arthritis Res Ther. 2010;12(1):R23.
   PubMed Web of Science ®Google Scholar
• Zamudio-Cuevas Y, Martínez-Flores K, Fernández-Torres J, et al. Monosodium urate crystals induce oxidative stress in human synoviocytes. Arthritis Res Ther. 2016;18(1):117.
   PubMedGoogle Scholar
• Carlson AK, McCutchen CN, June RK. Mechanobiological implications of articular cartilage crystals. Curr Opin Rheumatol. 2017;29(2):157–162.
   PubMed Web of Science ®Google Scholar
• Nasi S, Castelblanco M, Chobaz V, et al. Xanthine Oxidoreductase Is Involved in Chondrocyte Mineralization and Expressed in Osteoarthritic Damaged Cartilage. Front Cell Dev Biol. 2021 Feb;9(9):612440.
   PubMedGoogle Scholar
• Bertrand J, Kräft T, Gronau T, et al. BCP crystals promote chondrocyte hypertrophic differentiation in OA cartilage by sequestering Wnt3a. Ann Rheum Dis. 2020 Jul;79(7):975–984.
   PubMed Web of Science ®Google Scholar
• Wu X, Wakamiya M, Vaishnav S, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A. 1994;91(2):742–746.
   PubMed Web of Science ®Google Scholar
• Oliviero F, Galozzi P, Scanu A, et al. Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice. Nutrients. 2021;13(3):929.
   PubMed Web of Science ®Google Scholar
• Nasi S, So A, Combes C, et al. Interleukin-6 and chondrocyte mineralization act in tandem to promote experimental osteoarthritis. Ann Rheum Dis. 2016;75(7):1372–1379. https://doi.org/10.1136/annrheumdis-2015-207487.
   PubMed Web of Science ®Google Scholar
• Nasi S, HK EA, So A, et al. Revisiting the role of Interleukin 1α and 1β and NLRP3 inflammasome are not involved in the pathological features of murine meniscectomy model of osteoarthritis. Front Pharmacol. 2017;8:282.
   PubMed Web of Science ®Google Scholar
• Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum. 2009;60(1):281–289.
   PubMed Web of Science ®Google Scholar
• Liu-Bryan R, Scott P, Sydlaske A, et al. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005;52(9):2936–2946. https://doi.org/10.1002/art.21238.
   PubMedGoogle Scholar
• Masuda I, Hirose J. Animal models of pathologic calcification. Curr Opin Rheumatol. 2002;14(3):287–291.
   PubMed Web of Science ®Google Scholar
• Gurley KA, Chen H, Guenther C, et al. Mineral formation in joints caused by complete or joint-specific loss of ANK function. J Bone Miner Res. 2006;21(8):1238–1247.
   PubMed Web of Science ®Google Scholar
• Li Q, Pratt CH, Dionne LA, et al. Spontaneous asj-2J mutant mouse as a model for generalized arterial calcification of infancy: a large deletion/insertion mutation in the Enpp1 gene. PLoS One. 2014;9(12):e113542.
   PubMed Web of Science ®Google Scholar
• Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51.
   PubMed Web of Science ®Google Scholar
• Kuro-O M. Phosphate as a Pathogen of Arteriosclerosis and Aging. J Atheroscler Thromb. 2021;28(3):203–213.
   PubMed Web of Science ®Google Scholar
• Richette P, Doherty M, Pascual E, et al. 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020;79(1):31–38.
   PubMed Web of Science ®Google Scholar
• FitzGerald JD, Dalbeth N, Mikuls T, et al. American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res (Hoboken). 2020;72(6):744–760. https://doi.org/10.1002/acr.24180.
   PubMed Web of Science ®Google Scholar
• Misawa T, Takahama M, Kozaki T, et al. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14(5):454–460.
   PubMed Web of Science ®Google Scholar
• Phelps R. Appearance of chemotactic activity followingintracellular injection of monosodium urate crystals: effect of colchicine. J Lab Clin Med. 1970;71:622–631. Caner JEZ. Colchicine inhibition of chemotaxis.Arthritis Rheum. 1965;8:757–64.
   Google Scholar
• Chia EW, Grainger R, Harper JL. Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: a rationale for use of low-dose colchicine. Br J Pharmacol. 2008;153(6):1288–1295.
   PubMed Web of Science ®Google Scholar
• Paya M, Terencio MC, Ferrandiz ML, et al. Involvement of secretory phospholipase A2 activity in the zymosan air pouch model of inflammation. Br J Pharmacol. 1996;117(8):1773–1779.
   PubMed Web of Science ®Google Scholar
• So A, De Meulemeester M, Pikhlak A, et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 2010;62(10):3064–3076.
   PubMed Web of Science ®Google Scholar
• Schlesinger N, Alten RE, Bardin T, et al., Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann Rheum Dis. 2012;71(11):1839–1848.
   PubMed Web of Science ®Google Scholar
• ema.europa.eu [Internet], Amsterdam: EMA [Updated 31/01/2020 Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/ilaris Last accession on 10/04/2021
   Google Scholar
• So A, De Smedt T, Revaz S, et al. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther. 2007;9(2):R28.
   PubMed Web of Science ®Google Scholar
• Ghosh P, Cho M, Rawat G, et al. Treatment of acute gouty arthritis in complex hospitalized patients with anakinra. Arthritis Care Res (Hoboken). 2013;65(8):1381–1384.
   PubMed Web of Science ®Google Scholar
• Terkeltaub RA, Schumacher HR, Carter JD, et al. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis Res Ther. 2013;15(1):R25.
   PubMed Web of Science ®Google Scholar
• Zahid A, Li B, Kombe AJK, et al. Pharmacological Inhibitors of the NLRP3 Inflammasome. Front Immunol. 2019;10:2538.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Mueller JL, Vitari AC, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol. 2009;187(1):61–70.
   PubMed Web of Science ®Google Scholar
• Jiang H, He H, Chen Y, et al., Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med. 2017;214(11):3219–3238.
   PubMed Web of Science ®Google Scholar
• Klück V, Jansen TLTA, Janssen M, et al. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol. 2020;2(5):e270–e280.
   PubMedGoogle Scholar
• He H, Jiang H, Chen Y, et al. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat Commun. 2018;9(1):2550.
   PubMedGoogle Scholar
• Choi N, Yang G, Jang JH, et al. Loganin Alleviates Gout Inflammation by Suppressing NLRP3 Inflammasome Activation and Mitochondrial Damage. Molecules. 2021;26(4):1071.
   PubMed Web of Science ®Google Scholar
• Lin X, Wang H, An X, et al. Baeckein E suppressed NLRP3 inflammasome activation through inhibiting both the priming and assembly procedure: implications for gout therapy. Phytomedicine. 2021;84:153521.
   PubMed Web of Science ®Google Scholar
• Chiu HW, Li LH, Hsieh CY, et al. Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome. Sci Rep. 2019;9(1):5603.
   PubMedGoogle Scholar
• Clarke J. β-carotene blocks the inflammasome. Nat Rev Rheumatol. 2020;16(5):248.
   PubMed Web of Science ®Google Scholar
• Qiao CY, Li Y, Shang Y, et al. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages. Inflammopharmacology. 2020;28(6):1481–1493.
   PubMed Web of Science ®Google Scholar
• Yin C, Liu B, Wang P, et al. Eucalyptol alleviates inflammation and pain responses in a mouse model of gout arthritis. Br J Pharmacol. 2020;177(9):2042–2057.
   PubMed Web of Science ®Google Scholar
• Chen B, Li H, Ou G, et al. Curcumin attenuates MSU crystal-induced inflammation by inhibiting the degradation of IκBα and blocking mitochondrial damage. Arthritis Res Ther. 2019;21(1):193.
   PubMed Web of Science ®Google Scholar
• Ahn H, Lee GS. Riboflavin, vitamin B2, attenuates NLRP3, NLRC4, AIM2, and non-canonical inflammasomes by the inhibition of caspase-1 activity. Sci Rep. 2020;10(1):19091.
   PubMed Web of Science ®Google Scholar
• Dhanasekar C, Kalaiselvan S, Rasool M. Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-κB Activation. PLoS One. 2015;10(12):e0145093.
   PubMed Web of Science ®Google Scholar
• Yan Y, Jiang W, Spinetti T, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity. 2013;38(6):1154–1163.
   PubMed Web of Science ®Google Scholar
• Li X, Pan Y, Li W, et al. The role of noncoding RNAs in Gout. Endocrinology. 2020;161(11):bqaa165.
   PubMed Web of Science ®Google Scholar
• Zhang QB, Qing YF, Yin CC, et al. Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasome. Arthritis Res Ther. 2018;20(1):45.
   PubMedGoogle Scholar
• Liu P, Chen Y, Wang B, et al. Expression of microRNAs in the plasma of patients with acute gouty arthritis and the effects of colchicine and etoricoxib on the differential expression of microRNAs. Arch Med Sci. 2019;15(4):1047–1055.
   PubMed Web of Science ®Google Scholar
• Ding XQ, Wu WY, Jiao RQ, et al. Curcumin and allopurinol ameliorate fructose-induced hepatic inflammation in rats via miR-200a-mediated TXNIP/NLRP3 inflammasome inhibition. Pharmacol Res. 2018;137:64–75.
   PubMed Web of Science ®Google Scholar
• Wang W, Ding XQ, Gu TT, et al. Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. Free Radic Biol Med. 2015;83:214–226.
   PubMed Web of Science ®Google Scholar
• Zhao XJ, Yu HW, Yang YZ, et al. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 2018;18:124–137.
   PubMed Web of Science ®Google Scholar
• Wang Y. Tripterine ameliorates monosodium urate crystal-induced gouty arthritis by altering macrophage polarization via the miR-449a/NLRP3 axis. Inflamm Res. 2021;70(3):323–341.
   PubMed Web of Science ®Google Scholar
• McCarty DJ Jr. Crystal-induced inflammation; syndromes of gout and pseudogout. Geriatrics. 1963 Jun;18:467–478.
   PubMed Web of Science ®Google Scholar
• McCarty DJ Jr, Phelps P, Pyenson J. Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response. J Exp Med. 1966;124(1):99–114.
   PubMed Web of Science ®Google Scholar